Marcus Boehm, Director at Vyant Bio, Inc. (VYNT), bought 5,000 shares at $2.92 ($15K) on 2021-07-28, disclosed to the SEC on 2021-07-28.
Scheduled purchase ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VYNT | BUY | 2021-09-30 | $12K | — | Filing → |
| VYNT | BUY | 2021-08-26 | $13K | — | Filing → |
| VYNT | BUY | 2021-07-01 | $19K | — | Filing → |